DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Gäbler K, Behrmann I, Haan C.
JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms.
JAK-STAT 2013;
2 (03) e25025
Access:
We do not assume any responsibility for the contents of the web pages of other providers.